Veracyte to Release Second Quarter 2023 Financial Results on August 8, 2023
- Veracyte, Inc. will release financial results for Q2 2023 on August 8, 2023, which could positively impact the stock price if the results exceed expectations.
- None.
The conference call will be webcast live from the company’s website and will be available via the following link: https://edge.media-server.com/mmc/p/iwy5xkbf. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company’s website at https://investor.veracyte.com/events-presentations.
The conference call dial-ins can be accessed by registering at: https://register.vevent.com/register/BI62f03c15042b4d5dadeed4e37ed31fd8
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our high-performing tests enable clinicians to make more confident diagnostic, prognostic and treatment decisions for some of the most challenging diseases such as thyroid, prostate, breast, bladder and lung cancers, as well as interstitial lung diseases. We help patients avoid unnecessary procedures and speed time to diagnosis and appropriate treatment. In addition to making our tests available in the
View source version on businesswire.com: https://www.businesswire.com/news/home/20230719721261/en/
Investors
Shayla Gorman - Director, Investor Relations
investors@veracyte.com
(619) 393-1545
Media
Tracy Morris - Vice President of Global Corporate Communications
tracy.morris@veracyte.com
(650) 380-4413
Source: Veracyte, Inc.
FAQ
When will Veracyte release its financial results for Q2 2023?
What will be discussed during the conference call and webcast?
Where can I access the webcast replay?
How can I access the conference call dial-ins?
